AstraZeneca seeks U.S. approval for new COVID treatment
AstraZeneca has requested emergency use authorization from U.S. regulators for its new treatment to prevent COVID-19 for people who respond poorly to vaccines because of a weakened immune system.
Comentarios
Publicar un comentario
Leave a comment. Thanks!
Comentarios de Facebook